Showing results (161-170 of 186) with videos related to
Sort By:
Pageof 19
International Journal of Oncology|May 11, 2006
Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastomaMyung Jin Son, Hyun Seok Song, Mi Hyun Kim, et al.Neuro-Oncology|August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastomaMark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2013
A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant gliomaDavid A Reardon, Morris D Groves, Patrick Y Wen, et al.Communications Biology|September 25, 2023
In vivo label-free optical signatures of chemotherapy response in human pancreatic ductal adenocarcinoma patient-derived xenograftsJaena Park, Janet E Sorrells, Eric J Chaney, et al.Journal of Neuro-Oncology|June 8, 2020
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancerRachna Malani, Martin Fleisher, Priya Kumthekar, et al.Cancer|November 17, 2011
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic gliomaPierre Giglio, Megha Dhamne, Kenneth R Hess, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2013
Phase I study of GRN1005 in recurrent malignant gliomaJan Drappatz, Andrew Brenner, Eric T Wong, et al.Neuro-Oncology|March 5, 2008
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignanciesMorris D Groves, Michael J Glantz, Marc C Chamberlain, et al.Neuro-Oncology|March 4, 2008
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiformeVinay K Puduvalli, Pierre Giglio, Morris D Groves, et al.Breast Cancer Research and Treatment|September 17, 2013
Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white womenStephanie D Boone, Kathy B Baumgartner, Richard N Baumgartner, et al.Pageof 19